Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

52 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy and safety of antibody-drug conjugates in pretreated HER2-low metastatic breast cancer: A systematic review and network meta-analysis.
Schettini F, Nucera S, Pascual T, Martínez-Sáez O, Sánchez-Bayona R, Conte B, Buono G, Lambertini M, Punie K, Cejalvo JM, Arpino G, Vigneri P, Generali D, Ciruelos E, Cortés J, Gennari A, Muñoz M, Vidal Losada MJ, Tolaney SM, Prat A, Villacampa G. Schettini F, et al. Among authors: sanchez bayona r. Cancer Treat Rev. 2025 Jan;132:102865. doi: 10.1016/j.ctrv.2024.102865. Epub 2024 Dec 19. Cancer Treat Rev. 2025. PMID: 39709655 Free article. Review.
Uncovering Surgical Dynamics and Trends in Early Breast Cancer Stage at Diagnosis: Key Insights From a Two-Decade Argentine Database Analysis.
Mandó P, Fabiano V, Gomez Guasch S, Colucci G, Sánchez-Bayona R, Coló F, Loza M, Von Stecher F, Amat M, de la Vega M, Costanzo MV, Nervo A, Nadal J, Chacón R, Perazzo F; RCM Database Contributors. Mandó P, et al. Among authors: sanchez bayona r. JCO Glob Oncol. 2024 Nov;10:e2400123. doi: 10.1200/GO.24.00123. Epub 2024 Nov 27. JCO Glob Oncol. 2024. PMID: 39602672
Proactive assessment of patient reported outcomes in ovarian cancer studies: a systematic review and call for action in future studies.
Madariaga A, Sánchez-Bayona R, Kasherman L, Estrada-Lorenzo JM, Manso L, Tolosa P, Alva M, Lema L, González-Deza C, Ciruelos E, Valcarcel D, Lheureux S, Oza AM. Madariaga A, et al. Among authors: sanchez bayona r. Int J Gynecol Cancer. 2025 Jan 6:ijgc-2024-005883. doi: 10.1136/ijgc-2024-005883. Online ahead of print. Int J Gynecol Cancer. 2025. PMID: 39379328
Neoadjuvant Immune Checkpoint Inhibitors Plus Chemotherapy in Early Breast Cancer: A Systematic Review and Meta-Analysis.
Villacampa G, Navarro V, Matikas A, Ribeiro JM, Schettini F, Tolosa P, Martínez-Sáez O, Sánchez-Bayona R, Ferrero-Cafiero JM, Salvador F, Papakonstantinou A, Prat A, Oliveira M, Pascual T. Villacampa G, et al. Among authors: sanchez bayona r. JAMA Oncol. 2024 Oct 1;10(10):1331-1341. doi: 10.1001/jamaoncol.2024.3456. JAMA Oncol. 2024. PMID: 39207778
Abemaciclib for treating patients with HR+/HER2- metastatic breast cancer: a real-world study in France, Italy and Spain.
Blancas I, Grosjean J, Pedersini R, Buzzoni C, Sleilaty G, Molero A, Tamma A, Chouaki N, Atienza M, Emde A, Siddi S, Sanchez Bayona R, Del Mastro L, Fakhouri W. Blancas I, et al. Among authors: sanchez bayona r. Future Oncol. 2024;20(31):2371-2384. doi: 10.1080/14796694.2024.2368455. Epub 2024 Aug 8. Future Oncol. 2024. PMID: 39115881 Free PMC article.
Patritumab deruxtecan in HER2-negative breast cancer: part B results of the window-of-opportunity SOLTI-1805 TOT-HER3 trial and biological determinants of early response.
Brasó-Maristany F, Ferrero-Cafiero JM, Falato C, Martínez-Sáez O, Cejalvo JM, Margelí M, Tolosa P, Salvador-Bofill FJ, Cruz J, González-Farré B, Sanfeliu E, Òdena A, Serra V, Pardo F, Luna Barrera AM, Arumi M, Guerra JA, Villacampa G, Sánchez-Bayona R, Ciruelos E, Espinosa-Bravo M, Izarzugaza Y, Galván P, Matito J, Pernas S, Vidal M, Santhanagopal A, Sellami D, Esker S, Fan PD, Suto F, Vivancos A, Pascual T, Prat A, Oliveira M. Brasó-Maristany F, et al. Among authors: sanchez bayona r. Nat Commun. 2024 Jul 11;15(1):5826. doi: 10.1038/s41467-024-50056-y. Nat Commun. 2024. PMID: 38992028 Free PMC article.
Dietary carbohydrate quality index and incidence of obesity-related cancers in the "Seguimiento Universidad De Navarra" (SUN) prospective cohort.
Olmedo M, Santiago S, Romanos-Nanclares A, Aramendia-Beitia JM, Sanchez-Bayona R, Bes-Rastrollo M, Martinez-Gonzalez MA, Toledo E. Olmedo M, et al. Among authors: sanchez bayona r. Eur J Nutr. 2024 Oct;63(7):2449-2458. doi: 10.1007/s00394-024-03438-3. Epub 2024 May 30. Eur J Nutr. 2024. PMID: 38814364 Free PMC article.
Everolimus plus endocrine therapy beyond CDK4/6 inhibitors progression for HR+ /HER2- advanced breast cancer: a real-world evidence cohort.
Sánchez-Bayona R, Lopez de Sa A, Jerez Gilarranz Y, Sanchez de Torre A, Alva M, Echavarria I, Moreno F, Tolosa P, Herrero Lopez B, de Luna A, Lema L, Gamez Casado S, Madariaga A, López-Tarruella S, Manso L, Bueno-Muiño C, Garcia-Saenz JA, Ciruelos E, Martin M. Sánchez-Bayona R, et al. Breast Cancer Res Treat. 2024 Aug;206(3):551-559. doi: 10.1007/s10549-024-07324-8. Epub 2024 May 4. Breast Cancer Res Treat. 2024. PMID: 38703285
52 results